Nanomaterials for A431 Epidermoid Carcinoma Treatment
- Title
- Nanomaterials for A431 Epidermoid Carcinoma Treatment
- Creator
- Christobher S.; Kalitha Parveen P.; Easwaran M.; Bhotla H.K.; Kaliannan D.; Balasubramanian B.; Meyyazhagan A.
- Description
- Malignancy is the ancient sickness that causes an increased rate of mortality worldwide. Traditional malignant growth treatments that are clinically utilized comprise chemotherapy, radiotherapy, and medical procedure. Despite the fact that there have been motivating enhancements in the nanotechnology and biomedical field, malignant growth remains the most urgent condition to treat, as the central reason for mortality. Nanotechnology has the possibility to improve medication transport and delivery by modifying pharmacokinetics and conveyance, resulting in reduced negative reactions and in this manner improving precision. Some issues exist regarding destinations and the difficulties that occur, and the potential for success becomes closer with every discovery. Nanomaterials are smaller in size than organic macromolecules. More correctly, they as a rule have a width of many nanometers (nm), which makes them from 100 up to multiple times smaller than even one malignancy cell. Nanoparticles can occur in sizes running from 10 up to 400nm, and can likewise be used with a simple set up or a blend of pharmacologically dynamic medications, depending on a superficial level of properties. The various aspect of nanotechnology for malignant growth treatment include exact targeting of the lively segments in cell/tissues, producing upgrades responsive medication discharge, defeating natural obstructions, interfacing against disease dynamic system with imaging atoms, improving disease examination, and imaging. For the most part, nanoparticles burdened with mending operators are conveyed experimentally for firm malignancy treatment. Todays nanotechnology is a magnificent platform for the treatment of differing malignant growths. 2022, The Author(s), under exclusive license to Springer Nature Switzerland AG.
- Source
- Nanotechnology in the Life Sciences, pp. 211-235.
- Date
- 2022-01-01
- Publisher
- Springer Science and Business Media B.V.
- Subject
- Drug delivery; Nanoparticles; Nanotherapeutics; Properties; Skin carcinoma
- Coverage
- Christobher S., Department of Zoology, Nallamuthu Gounder Mahalingam College, Tamil Nadu, Pollachi, India; Kalitha Parveen P., PG Department of Zoology, Hajee Karutha Rowther Howdia College of Arts and Science, Tamil Nadu, Uthamapalayam, India; Easwaran M., Bioknowl Insights Private Limited, Tamil Nadu, Coimbatore, India; Bhotla H.K., Bioknowl Insights Private Limited, Tamil Nadu, Coimbatore, India; Kaliannan D., Zoonosis Research Center, Department of Infection Biology, School of Medicine, Wonkwang University, Iksan, South Korea; Balasubramanian B., Department of Food Science and Biotechnology, College of Life Sciences, Sejong University, Seoul, South Korea; Meyyazhagan A., Department of Life Sciences, CHRIST (Deemed to be University), Bangalore, India
- Rights
- Restricted Access
- Relation
- ISSN: 25238027
- Format
- Online
- Language
- English
- Type
- Book chapter
Collection
Citation
Christobher S.; Kalitha Parveen P.; Easwaran M.; Bhotla H.K.; Kaliannan D.; Balasubramanian B.; Meyyazhagan A., “Nanomaterials for A431 Epidermoid Carcinoma Treatment,” CHRIST (Deemed To Be University) Institutional Repository, accessed April 22, 2025, https://archives.christuniversity.in/items/show/18697.